| Literature DB >> 36082066 |
Jiahuan Wu1, Tian Zhan2, Honggang Sun3, Fanbo Wang4.
Abstract
Thyroid disease has always been a common and frequent disease in clinical medicine, and its disease detection rate has been increasing year by year. Thyroid diseases are mainly divided into two categories: thyroid diseases treated by medical treatment and thyroid diseases treated by surgery. Thyroid cancer has also become one of the most common malignant secretory tumor diseases today. Ultrasound examination is a commonly used method for diagnosing thyroid diseases. During the diagnosis process, doctors need to observe the characteristics of ultrasound images and combine professional knowledge and clinical experience to give the patient's disease status. With the improvement of people's living standards and health awareness, thyroid disease has become an important issue that plagues the health of Chinese residents. Therefore, people and medical workers are paying more attention to thyroid disease. In recent years, various ultrasound technologies have been applied in the differential diagnosis of benign and malignant thyroid nodules and have played an important role in the diagnosis. This article aims to study the application value of SMI technology (ultra-microvascular imaging technology) and contrast-enhanced ultrasound in the differential diagnosis of thyroid benign and malignant nodules. It conducts diagnostic experiments and analysis on some cases of benign and malignant thyroid nodules through the use of SMI diagnostic methods and contrast-enhanced ultrasound examination methods. And the ROC curve was used to calculate the sensitivity of SMI technology and ultrasound for the identification and diagnosis of thyroid benign and malignant nodules, and the results were 0.83 and 0.81, respectively. It is concluded that SMI technology and contrast-enhanced ultrasound examination have good diagnostic efficiency and application value for the identification and diagnosis of thyroid benign and malignant nodules.Entities:
Mesh:
Year: 2022 PMID: 36082066 PMCID: PMC9436616 DOI: 10.1155/2022/6157026
Source DB: PubMed Journal: Contrast Media Mol Imaging ISSN: 1555-4309 Impact factor: 3.009
Figure 1SMI technology display.
Figure 2The basic flow of the SMI algorithm.
Figure 3The basic flow of the contrast-enhanced ultrasound motion correction algorithm.
Ultrasonography results of SMI nodules.
| ACR TI-RADS classification | Benign | Malignant | Predicted malignancy rate | Actual malignancy rate (%) |
|---|---|---|---|---|
| TR3 | 4 | 3 | <20% | 15 |
| TR4 | 4 | 3 | <20% | 15 |
| TR5 | 2 | 4 | >30% | 40 |
Note. ACR TI-RADS, American Society of Radiology Thyroid Imaging Report and Data System.
Figure 4Nodule blood flow distribution pattern in SMI technology. (a) Statistics of the number of SMI blood flow distribution patterns. (b) Proportion of SMI blood flow distribution patterns.
Results of contrast-enhanced ultrasound nodules.
| ACR ti-RADS classification | Benign | Malignant | Predicted malignancy rate | Actual malignancy rate (%) |
|---|---|---|---|---|
| TR3 | 5 | 2 | <20% | 10 |
| TR4 | 3 | 4 | <30% | 20 |
| TR5 | 2 | 4 | >10% | 20 |
Figure 5Contrast-enhanced ultrasound examination of nodule blood flow distribution pattern. (a) Statistics of the number of blood flow distribution patterns (b). Proportion of blood flow distribution patterns.
Figure 6ROC curve of SMI and contrast-enhanced ultrasound.